Nanotechnology could enhance traditional Chinese medicine delivery, promising improved clinical outcomes

This review in the Journal of Nanobiotechnology explores how nanotechnology enhances the delivery of traditional Chinese medicines (TCMs), overcoming challenges like poor solubility and limited bioavailability. Nanocarriers like liposomes and nanoparticles improve TCM delivery, offering greater therapeutic effectiveness and reduced side effects, but face challenges in biocompatibility and stability for clinical use.

Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight – Pharmaceutical Technology

After splashing out $27.8bn for Horizon Therapeutics, Amgen is now seeing growth with drugs like Tepezza, Krystexxa, and Uplizna. Credits: Marlon Trottmann/Shutterstock.com Amgen has announced

October 31, 2024

Cell donors are essential for new therapies. They need to be taken care of

Cutting-edge FDA-approved therapies made from human cells are now being used to treat cancer, diabetes, and other diseases. Currently, most approved cell-based therapies use an

July 24, 2024

Revolutionary CAR T-cell therapy shows promise in reversing age-related metabolic dysfunction

study evaluates senolytic CAR T-cell therapy targeting uPAR-positive cells in aged mice, showing its effectiveness in mitigating age-related metabolic dysfunction and offering a potential long-lasting

January 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.